Ovarian Cyst
Studies by B. Kumbak and co-authors describe new findings in ovarian cyst
Published in Biotech Business Week, June 15th, 2009
According to recent research from Turkey, "To evaluate the effect of basal ovarian cysts and also the impact of aspiration of those cysts at the onset of an assisted reproductive treatment (ART) cycle on stimulation characteristics and treatment outcome. A retrospective study of 162 normoresponder patients with basal cysts from whom at least five oocytes were retrieved was performed."
"They all received mid-luteal GnRH-a long protocol. Of 162 patients, 79 with basal cysts of 29.4 +/- A 9.0 mm and initial estradiol (E2) of 221.2 +/- A 24.3 pg/ml underwent cyst aspiration on day 3 and stimulation was initiated when E2 fell to < 70 pg/ml. In the remaining 83 patients...
This article not available for purchase.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Academy of Otolaryngology -- Head and Neck Surgery
ENT Society releases novel clinical practice guideline manual - American College of Chest Physicians
News briefs from the June issue of CHEST - American Society for Radiation Oncology
External beam partial breast irradiation most cost-effective treatment - American Society of Plastic Surgeons
Surgery in patients with RA is often 'too little, too late' - BioMed Central
'Shock and kill' research gives new hope for HIV-1 eradication - BioMed Central
Resilin springs simplify the control of crustacean limb movements - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
